{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:38:33Z","timestamp":1791329913937,"version":"4.3.1"},"update-to":[{"DOI":"10.1002\/14651858.cd013776","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000}}],"reference-count":175,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013776.pub2","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T02:22:50Z","timestamp":1638325370000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Blue versus white light for transurethral resection of non-muscle invasive bladder cancer"],"prefix":"10.1002","volume":"2021","author":[{"given":"Philipp","family":"Maisch","sequence":"additional","affiliation":[{"name":"Department of Urology; University of Ulm; Ulm Germany"},{"name":"Department of Urology; Rechts der Isar Medical Center, Technical University of Munich; Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Koziarz","sequence":"additional","affiliation":[{"name":"Faculty of Medicine; University of Toronto; Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Vajgrt","sequence":"additional","affiliation":[{"name":"University of Minnesota Medical School; Minneapolis, MN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Narayan","sequence":"additional","affiliation":[{"name":"Department of Urology; Emory University; Atlanta Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Ha","family":"Kim","sequence":"additional","affiliation":[{"name":"Yonsei Wonju Medical Library; Yonsei University Wonju College of Medicine; Wonju Korea, South"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Dahm","sequence":"additional","affiliation":[{"name":"Urology Section; Minneapolis VA Health Care System; Minneapolis Minnesota USA"},{"name":"Department of Urology; University of Minnesota; Minneapolis Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,12,1]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD013776.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/j.1464-410X.2004.05715","article-title":"5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta\/T1 bladder cancer","volume":"96","author":"Babjuk","year":"2005","journal-title":"BJU International"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD013776.pub2-BIB0002|cit2","first-page":"15","article-title":"Fluorescence cystoscopy in the diagnostics and treatment of superficial urinary bladder tumors","volume":"11","author":"Babjuk","year":"2005","journal-title":"Casopis L\u00e9karu Cesk\u00fdch"},{"issue":"4","key":"10.1002\/14651858.CD013776.pub2-BIB0003|cit3","first-page":"1279","article-title":"Improved diagnosis and long-term recurrence rate reduction for non-muscle-invasive bladder cancer patients undergoing fluorescent hexylaminolevulinate photodynamic diagnosis","volume":"58","author":"Dr\u0103goescu","year":"2017","journal-title":"Romanian Journal of Morphology and Embryology"},{"issue":"1","key":"10.1002\/14651858.CD013776.pub2-BIB0004|cit4","first-page":"123","article-title":"Photodynamic diagnosis of non-muscle invasive bladder cancer using hexaminolevulinic acid","volume":"52","author":"Maria","year":"2011","journal-title":"Romanian Journal of Morphology and Embryology"},{"issue":"9","key":"10.1002\/14651858.CD013776.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1569-9056(11)61661-8","article-title":"Use of hexaminolevulinate improves diagnosis sensitivity and treat ment efficiency of nonmuscle invasive bladder cancer","volume":"10","author":"Maria","year":"2011","journal-title":"European Urology, Supplements"},{"issue":"3","key":"10.1002\/14651858.CD013776.pub2-BIB0006|cit6","first-page":"S211","article-title":"Photodynamic diagnosis and treatment of non-muscle invasive bladder cancer using hexaminolevulinic acid","volume":"82","author":"Maria","year":"2013","journal-title":"Urology"},{"issue":"1","key":"10.1002\/14651858.CD013776.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"e958","DOI":"10.1016\/S1569-9056(12)60955-5","article-title":"Value of hexaminolevulinate fluorescent cystoscopy and resection in the management of non-muscle invasive bladder cancer","volume":"11","author":"Maria","year":"2012","journal-title":"European Urology, Supplements"},{"issue":"4","key":"10.1002\/14651858.CD013776.pub2-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.urology.2006.12.023","article-title":"Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study","volume":"69","author":"Denzinger","year":"2007","journal-title":"Urology"},{"issue":"5","key":"10.1002\/14651858.CD013776.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/j.1464-410X.2007.07314.x.","article-title":"Does photodynamic transurethral resection of bladder tumour improve the outcome of initial T1 high-grade bladder cancer? A long-term follow-up of a randomized study","volume":"101","author":"Denzinger","year":"2008","journal-title":"BJU International"},{"issue":"5","key":"10.1002\/14651858.CD013776.pub2-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/j.1464-410X.2007.07314.x","article-title":"Does photodynamic transurethral resection of bladder tumour improve the outcome of initial T1 high-grade bladder cancer? A long-term follow-up of a randomized study","volume":"101","author":"Denzinger","year":"2008","journal-title":"BJU International"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0011|cit11","unstructured":"Trial to compare the gain of photodynamic diagnostic during transuretral resektion of bladder cancer followed by intravesical chemotherapy against white-light-TURB followed by intravesical standard maintenance chemotherapy www.clinicaltrialsregister.eu\/ctr-search\/trial\/2009-012275-98\/DE"},{"issue":"1","key":"10.1002\/14651858.CD013776.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0022-5347(05)64833-1","article-title":"Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors","volume":"168","author":"Filbeck","year":"2002","journal-title":"Journal of Urology"},{"issue":"10","key":"10.1002\/14651858.CD013776.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1007\/s00120-003-0355-y","article-title":"Clinically relevant reduction of recurrence of superficial bladder tumor with 5-aminolevulinic acid-induced fluorescence diagnosis. Results of a 5 year study","volume":"42","author":"Filbeck","year":"2003","journal-title":"Urologe A"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4137\/cmo.s1012","article-title":"Photodynamic diagnosis for superficial bladder cancer: do all risk-groups profit equally from oncological and economic long-term results?","volume":"3","author":"Otto","year":"2009","journal-title":"Clinical Medicine Insights. Oncology"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0015|cit15","first-page":"A125","article-title":"HAL blue light cystoscopy in high-risk non-muscle invasive bladder cancer-re-turbt recurrence rates in a prospective, randomized study","volume":"24","year":"2010","journal-title":"Journal of Endourology"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0016|cit16","first-page":"6","article-title":"High-risk non-muscle invasive bladder cancer-\u201cthe real deal\u201d for blue light cystoscopy and TURBT?","volume":"106","year":"2010","journal-title":"BJU International"},{"issue":"3","key":"10.1002\/14651858.CD013776.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.urology.2010.02.067","article-title":"HAL blue-light cystoscopy in high-risk nonmuscle-invasive bladder cancer-re-TURBT recurrence rates in a prospective, randomized study","volume":"76","author":"Geavlete","year":"2010","journal-title":"Urology"},{"issue":"4","key":"10.1002\/14651858.CD013776.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1569-9056(13)60030-5","article-title":"Hexaminolevulinate fluorescence versus standard white light cystoscopy-does blue light really make a difference in the long run?","volume":"11","year":"2012","journal-title":"European Urology, Supplements"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0019|cit19","first-page":"A147","article-title":"Four-year non-muscle invasive bladder cancer recurrence rates-a prospective, randomized comparison between hexaminolevulinate blue light and standard white light cystoscopy","volume":"27","year":"2013","journal-title":"Journal of Endourology"},{"issue":"3","key":"10.1002\/14651858.CD013776.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.urology.2011.07.434","article-title":"Treatment changes and long-term recurrence rates after hal fluorescence cystoscopy: does blue light really make a difference in the long run?","volume":"78","year":"2011","journal-title":"Urology"},{"issue":"2","key":"10.1002\/14651858.CD013776.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S1569-9056(11)60534-4","article-title":"Treatment changes and long-term recurrence rates after HAL fluorescence cystoscopy-does blue light really make a difference in the long run?","volume":"10","year":"2011","journal-title":"European Urology, Supplements"},{"issue":"4","key":"10.1002\/14651858.CD013776.pub2-BIB0022|cit22","first-page":"e661","article-title":"Treatment changes and long-term recurrence rates after HAL fluorescence cystoscopy-does blue light really make a difference in the long run?","volume":"185","year":"2011","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0023|cit23","first-page":"A288","article-title":"Treatment changes and long-term recurrence rates after hal fluorescence cystoscopy: a prospective, randomized, long term comparison to the standard approach","volume":"25","year":"2011","journal-title":"Journal of Endourology"},{"issue":"1","key":"10.1002\/14651858.CD013776.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"e955","DOI":"10.1016\/S1569-9056(12)60952-X","article-title":"A prospective, randomized comparison between the hexaminolevulinate blue light and the standard white light cystoscopy concerning the long term recurrence rates in nonmuscle invasive bladder cancer cases","volume":"11","year":"2012","journal-title":"European Urology, Supplements"},{"issue":"4","key":"10.1002\/14651858.CD013776.pub2-BIB0025|cit25","first-page":"e511","article-title":"A prospective, randomized comparison between the hexaminolevulinate blue light and the standard white light cystoscopy concerning the long term recurrence rates in non-muscle invasive bladder cancer cases","volume":"187","year":"2012","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0026|cit26","first-page":"A92","article-title":"Hexaminolevulinate fluorescence versus standard white light cystoscopy:\u00a0does blue light really make a difference in the long run?","volume":"26","year":"2012","journal-title":"Journal of Endourology"},{"issue":"4","key":"10.1002\/14651858.CD013776.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1464-410X.2011.10374.x.","article-title":"Treatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)?","volume":"109","author":"Geavlete","year":"2012","journal-title":"BJU International"},{"issue":"4","key":"10.1002\/14651858.CD013776.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"e523","DOI":"10.1016\/j.juro.2013.02.2633","article-title":"Four-year non-muscle invasive bladder cancer recurrence rates-a prospective, randomized comparison between hexaminolevulinate blue light and standard white light cystoscopy","volume":"189","author":"Geavlete","year":"2013","journal-title":"Journal of Urology"},{"issue":"5","key":"10.1002\/14651858.CD013776.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s11255-013-0603-z","article-title":"Hexaminolevulinate-guided transurethral resection of non-muscle-invasive bladder cancer does not reduce the recurrence rates after a 2-year follow-up: a prospective randomized trial","volume":"46","author":"Gkritsios","year":"2014","journal-title":"International Urology and Nephrology"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0030|cit30","unstructured":"Placebo controlled, randomized trial, comparing the efficacy of white light cystoscopy with the fluorescence cystoscopy with the use of hexaminolevulinate, regarding the diagnosis and treatment of bladder cancer upload.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000002279"},{"issue":"8 Pt 2","key":"10.1002\/14651858.CD013776.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"E297","DOI":"10.1111\/j.1464-410X.2011.10090.x.","article-title":"Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta\/T1 patients-a randomized two-centre study","volume":"108","author":"Hermann","year":"2011","journal-title":"BJU International"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0032|cit32","unstructured":"A randomized, comparative study of Hexvix fluorescence cystoscopy and standard cystoscopy in patients with non-invasive bladder cancer clinicaltrials.gov\/ct2\/show\/NCT00412971"},{"issue":"2","key":"10.1002\/14651858.CD013776.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.urology.2012.03.067","article-title":"Hexaminolevulinate-induced fluorescence versus white light during transurethral resection of noninvasive bladder tumor: does it reduce recurrences?","volume":"80","author":"Karaolides","year":"2012","journal-title":"Urology"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0034|cit34","first-page":"A88","article-title":"Hexaminolevulinate induced fluorescence versus white light during transurethral resection of non-invasive bladder tumor. Does it reduce recurrences?","volume":"25","author":"Skolarikos","year":"2012","journal-title":"Journal of Endourology"},{"issue":"2","key":"10.1002\/14651858.CD013776.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0022-5347(05)64661-7","article-title":"Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy","volume":"168","author":"Kriegmair","year":"2002","journal-title":"Journal of Urology"},{"issue":"8","key":"10.1002\/14651858.CD013776.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.urolonc.2014.04.005","article-title":"Assessment of diagnostic gain with hexaminolevulinate (HAL) in the setting of newly diagnosed non-muscle-invasive bladder cancer with positive results on urine cytology","volume":"32","author":"Neuzillet","year":"2014","journal-title":"Urologic Oncology"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0037|cit37","unstructured":"A randomised study of \u201cbluelight\u201d hexyl amino levulinic acid (HAL) photodynamic assisted resection of bladder tumours versus conventional \u201cwhite light\u201d transurethral resection of newly diagnosed bladder tumours comparing rates of tumour recurrence over on www.clinicaltrialsregister.eu\/ctr-search\/trial\/2004-002760-16\/results"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0038|cit38","first-page":"8","article-title":"Long term follow up of a prospective randomised trial of Hexylaminolevulinate (HEXVIX\u00ae) photodynamic diagnosis (PDD) assisted versus conventional white-light transurethral resection (TURBT) in newly presenting non-muscle invasive bladder cancer (NMIBC)","volume":"113","author":"Ray","year":"2014","journal-title":"BJU International"},{"issue":"4","key":"10.1002\/14651858.CD013776.pub2-BIB0039|cit39","first-page":"e237","article-title":"Long term follow up of a prospective randomised trial of hexylaminolevulinate (Hexvix\u00ae) photodynamic diagnosis (PDD) assisted versus conventional white-light transurethral resection (TURBT) in newly presenting non-muscle invasive bladder cancer (NMIBC)","volume":"191","author":"Ray","year":"2014","journal-title":"Journal of Urology"},{"issue":"4S","key":"10.1002\/14651858.CD013776.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1016\/j.juro.2014.02.856","article-title":"Long term follow up of a prospective randomised trial of Hexylaminolevulinate (HEXVIX \u00ae) photodynamic diagnosis (PDD) assisted versus conventional white-light transurethral resection (TURBT) in newly presenting non-muscle invasive bladder cancer (NMIBC)","volume":"191","author":"Gan","year":"2014","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0041|cit41","unstructured":"A randomised study of 'bluelight' hexyl aminolevulinic acid (HAL) photodynamic assisted resection of bladder tumours versus conventional 'whitelight' transurethral resection of newly diagnosed bladder tumours comparing rates of tumour recurrence over one www.isrctn.com\/ISRCTN14275387"},{"issue":"4","key":"10.1002\/14651858.CD013776.pub2-BIB0042|cit42","first-page":"e661","article-title":"A prospective randomised trial of hexylaminolevulinate (HAL) assisted transurethral resection (TURBT) plus single shot intravesical mitomycinc (MMC) versus white light TURBT plus single shot MMC in newly presenting bladder cancer","volume":"185","author":"O'Brien","year":"2011","journal-title":"Journal of Urology"},{"issue":"8","key":"10.1002\/14651858.CD013776.pub2-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/bju.12355","article-title":"Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour (TURBT) plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-invasive bladder cancer","volume":"112","author":"O'Brien","year":"2013","journal-title":"BJU International"},{"issue":"2","key":"10.1002\/14651858.CD013776.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1569-9056(11)60428-4","article-title":"A prospective randomised trial of Hexylaminolevulinate (Hexvix) assisted transurethral resection (TURBT) plus single shot intravesical mitomycin (MMC) versus conventional white light TURBT plus single shot MMC in newly presenting bladder cancer","volume":"10","author":"O'Brien","year":"2011","journal-title":"European Urology, Supplements"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0045|cit45","first-page":"8","article-title":"A prospective randomised trial of Hexylaminolevulinate (HAL) assisted transurethral resection (TURBT) plus single shot intravesical MitomycinC (MMC) versus white light TURBT plus single shot MMC in newly presenting bladder cancer","volume":"108","author":"Ray","year":"2011","journal-title":"BJU International"},{"issue":"8 Pt 2","key":"10.1002\/14651858.CD013776.pub2-BIB0046|cit46","first-page":"E297","article-title":"Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta\/T1 patients: a randomized two-centre study","volume":"108","author":"Koenig","year":"2011","journal-title":"BJU International"},{"issue":"6","key":"10.1002\/14651858.CD013776.pub2-BIB0047|cit47","first-page":"734","article-title":"Clinical significance of macroscopic 5-aminolevulinic acid (ALA)-inducer fluorescence in transurethral resection of non-invasive bladder cancer","volume":"49","author":"Danilchenko","year":"2003","journal-title":"Voprosy Onkologii"},{"issue":"3","key":"10.1002\/14651858.CD013776.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S1569-9056(05)80879-6","article-title":"Reducing the risk of cancer recurrence and progression in patients with superficial bladder tumour with 5-aminolevulinic acid-induced fluore scence diagnosis. Results of a prospective randomized 5-year study","volume":"4","author":"\u00a0Koenig","year":"2005","journal-title":"European Urology, Supplements"},{"issue":"6","key":"10.1002\/14651858.CD013776.pub2-BIB0049|cit49","first-page":"497","article-title":"The impact of ALA (5-aminolevulinic acid)-fluorescence detection on the prognosis of superficial bladder cancer. A 1-year survival analysis","volume":"35","author":"Koenig","year":"2004","journal-title":"Aktuelle Urologie"},{"issue":"4","key":"10.1002\/14651858.CD013776.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0022-5347(05)66442-7","article-title":"Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer","volume":"165","author":"Riedl","year":"2001","journal-title":"Journal of Urology"},{"issue":"4","key":"10.1002\/14651858.CD013776.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0022-5347(18)35068-7","article-title":"Fluorescence detection with 5-aminolevulinic acid (ALA) reduces the risk of tumor recurrence and progression in patients with superficial bladder cancer: 5 year results of a prospective randomized trial","volume":"173","author":"Sachs","year":"2005","journal-title":"Journal of Urology"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD013776.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0022-5347(18)35068-7","article-title":"Fluorescence detection with 5-aminolevulinic acid (ALA) reduces the risk of tumor recurrence and progression in patients with superficial bladder cancer-5 year results of a prospective randomized trial","volume":"173","author":"Sachs","year":"2005","journal-title":"Journal of Urology"},{"issue":"5","key":"10.1002\/14651858.CD013776.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"e2236","DOI":"10.1016\/S1569-9056(17)31377-5","article-title":"Long-term benefit of fluorescent cystoscopy-assisted transurethral resection in patients with non-muscle invasive bladder cancer is dependent on quality of surgery","volume":"16","year":"2017","journal-title":"European Urology, Supplements"},{"issue":"4","key":"10.1002\/14651858.CD013776.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"351","DOI":"10.5173\/ceju.2019.0003","article-title":"Efficacy of fluorescent cystoscopy-assisted transurethral resection in patients with non-muscle invasive bladder cancer and quality of surgery: post-hoc analysis of \u0430 prospective randomized study","volume":"72","year":"2019","journal-title":"Central European Journal of Urology"},{"issue":"1","key":"10.1002\/14651858.CD013776.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"e1003","DOI":"10.1016\/S1569-9056(14)60986-6","article-title":"Recurrence prevention by combination of photodynamic diagnosis-assisted transurethral resection of the bladder and single postoperative intravesical chemotherapy instillation in patients with nonmuscle-invasive bladder cancer","volume":"13","year":"2014","journal-title":"European Urology, Supplements"},{"issue":"3","key":"10.1002\/14651858.CD013776.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1016\/S1569-9056(16)60210-5","article-title":"Transurethral resection guided by photodynamic diagnosis can prevent progression in nonmuscle invasive bladder cancer patients","volume":"15","year":"2016","journal-title":"European Urology, Supplements"},{"issue":"5","key":"10.1002\/14651858.CD013776.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00345-016-1927-y","article-title":"Results of a prospective randomized study assessing the efficacy of fluorescent cystoscopy-assisted transurethral resection and single instillation of doxorubicin in patients with non-muscle-invasive bladder cancer","volume":"35","author":"Rolevich","year":"2017","journal-title":"World Journal of Urology"},{"issue":"4","key":"10.1002\/14651858.CD013776.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0022-5347(09)61928-5","article-title":"Transurethral resection of non-muscle-invasive bladder transitional cell cancers with or without 5-ALA under visible and fluorescent light-multicenter phase III clinical trial","volume":"181","author":"Schumacher","year":"2009","journal-title":"Journal of Urology"},{"issue":"2","key":"10.1002\/14651858.CD013776.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.eururo.2009.10.030","article-title":"Transurethral resection of non-muscle-invasive bladder transitional cell cancers with or without 5-aminolevulinic acid under visible and fluorescent light: results of a prospective, randomised, multicentre study","volume":"57","author":"Schumacher","year":"2010","journal-title":"European Urology"},{"issue":"1","key":"10.1002\/14651858.CD013776.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"e957","DOI":"10.1016\/S1569-9056(12)60954-3","article-title":"Long-term reduction in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy","volume":"11","author":"Burger","year":"2012","journal-title":"European Urology, Supplements"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0061|cit61","unstructured":"A randomized, comparative, controlled phase III, multicenter study of Hexvix fluorescence cystoscopy and white light cystoscopy in the detection of papillary bladder cancer and the early recurrence rate in patients with bladder cancer www.drks.de\/drks_web\/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00004103"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0062|cit62","unstructured":"A randomized, comparative, controlled phase iii, multicenter study of hexvix fluorescence cystoscopy and white light cystoscopy in the detection of papillary bladder cancer and the early recurrence rate in patients with bladder cancer www.clinicaltrialsregister.eu\/ctr-search\/search?query=2004-002259-15"},{"issue":"4","key":"10.1002\/14651858.CD013776.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.urology.2009.07.1140","article-title":"Hexaminolevulinate new data: results from the recurrence study","volume":"74","author":"Burger","year":"2009","journal-title":"Urology"},{"issue":"1","key":"10.1002\/14651858.CD013776.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.juro.2012.03.007","article-title":"Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy","volume":"188","author":"Stenzl","year":"2012","journal-title":"Journal of Urology"},{"issue":"4","key":"10.1002\/14651858.CD013776.pub2-BIB0065|cit65","first-page":"e673","article-title":"Long-term clinical benefit of hexaminolevulinate enabled fluorescence cystoscopy","volume":"187","author":"Grossman","year":"2012","journal-title":"Journal of Urology"},{"issue":"1","key":"10.1002\/14651858.CD013776.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.juro.2012.03.00","article-title":"Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy","volume":"188","author":"Grossman","year":"2012","journal-title":"Journal of Urology"},{"issue":"2","key":"10.1002\/14651858.CD013776.pub2-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3233\/BLC-160048","article-title":"The impact of blue light cystoscopy with hexaminolevulinate (HAL) on progression of bladder cancer-a new analysis","volume":"27","author":"Kamat","year":"2016","journal-title":"Bladder Cancer"},{"issue":"4","key":"10.1002\/14651858.CD013776.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0022-5347(09)61931-5","article-title":"Hexaminolevulinate fluorescence cystoscopy improves detection and resection of papillary bladder cancer lesions and reduces early recurrences","volume":"181","author":"Karl","year":"2009","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0069|cit69","unstructured":"Study to improve detection and early recurrence rate in bladder cancer patients using Hexvix fluorescence cystoscopy clinicaltrials.gov\/ct2\/show\/NCT00233402"},{"issue":"4","key":"10.1002\/14651858.CD013776.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1569-9056(09)60995-7","article-title":"Hexvix\u00ae fluorescence cystoscopy improves detection and resection of papillary bladder cancer and reduces early recurrence: a multicentre, prospective, randomized study","volume":"8","year":"2009","journal-title":"European Urology, Supplements"},{"issue":"5","key":"10.1002\/14651858.CD013776.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/j.juro.2010.06.148","article-title":"Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer","volume":"184","author":"Stenzl","year":"2010","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0072|cit72","first-page":"A106","article-title":"Photodynamic diagnosis (PDD) and photodynamic treatment (PRT) in bladder cancer","volume":"17","author":"Stenzl","year":"2010","journal-title":"International Journal of Urology"},{"issue":"5","key":"10.1002\/14651858.CD013776.pub2-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1002\/cncr.25523","article-title":"Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy: a multicenter randomized, double-blind, placebo-controlled trial","volume":"117","author":"Stenzl","year":"2011","journal-title":"Cancer"},{"issue":"4","key":"10.1002\/14651858.CD013776.pub2-BIB0074|cit74","first-page":"e608","article-title":"Blue light flexible cystoscopy (BLFC) with hexaminolevulinate (HAL) and white light flexible cystoscopy: a prospective, comparative, within-patient controlled multicenter phase 3 study in the detection of bladder cancer during surveillance","volume":"197","author":"Patel","year":"2017","journal-title":"Journal of Urology"},{"issue":"5","key":"10.1002\/14651858.CD013776.pub2-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.juro.2017.11.096","article-title":"Efficacy and safety of blue light flexible cystoscopy with hexaminolevulinate in the surveillance of bladder cancer: a phase III, comparative, multicenter study","volume":"199","author":"Daneshmand","year":"2018","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0076|cit76","unstructured":"A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting clinicaltrials.gov\/show\/NCT02560584"},{"issue":"1","key":"10.1002\/14651858.CD013776.pub2-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/bju.14481","article-title":"Flexible blue light study group collaborators. Patient-reported outcomes of blue-light flexible cystoscopy with hexaminolevulinate in the surveillance of bladder cancer: results from a prospective multicentre study","volume":"123","author":"Smith","year":"2019","journal-title":"BJU International"},{"issue":"6","key":"10.1002\/14651858.CD013776.pub2-BIB0078|cit78","first-page":"734","article-title":"Clinical significance of macroscopic 5-aminolevulinic acid (ALA)-inducer florescence at transurethral resections of superficial bladder cancer","volume":"49","author":"Daniltchenko","year":"2003","journal-title":"Voprosy Onkologii"},{"issue":"6","key":"10.1002\/14651858.CD013776.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1055\/s-2004-818544","article-title":"The impact of ALA (5-aminolevulinic acid)-fluorescence detection on the prognosis of superficial bladder cancer","volume":"35","author":"Daniltchenko","year":"2004","journal-title":"Aktuelle Urologie"},{"issue":"6","key":"10.1002\/14651858.CD013776.pub2-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1097\/01.ju.0000181814","article-title":"Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study","volume":"174","author":"Daniltchenko","year":"2005","journal-title":"Journal of Urology"},{"issue":"1","key":"10.1002\/14651858.CD013776.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/S1569-9056(14)60025-7","article-title":"Comparison of white-light, photodynamic diagnosis and narrow-band imaging for the detection of non-muscle invasive bladder cancer: results from a randomized multicenter diagnostic phase-III study","volume":"13","author":"\u00a0Zumbe","year":"2014","journal-title":"European Urology, Supplements"},{"issue":"6","key":"10.1002\/14651858.CD013776.pub2-BIB0082|cit82","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.purol.2019.04.001","article-title":"Is a routine second transurethral resection of the bladder still necessary after hexaminol\u00e9vulinate photodynamic diagnosis-assisted TURBT?","volume":"29","author":"Walz","year":"2019","journal-title":"Progr\u00e8s en Urologie"},{"issue":"2","key":"10.1002\/14651858.CD013776.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"e1608","DOI":"10.1016\/S1569-9056(18)31960-2","article-title":"DaBlaCa-11: Photodynamic diagnosis in flexible cystoscopy-initial findings in a randomized controlled trial","volume":"17","author":"\u00a0Munk Nielsen","year":"2018","journal-title":"European Urology, Supplements"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.urology.2016.11.032","article-title":"Comparison of white light, photodynamic diagnosis, and narrow-band Imaging in detection of carcinoma in situ or flat dysplasia at transurethral resection of the bladder: the DaBlaCa-8 study","volume":"102","author":"Drejer","year":"2017","journal-title":"Urology"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.urology.2019.12.002","article-title":"DaBlaCa-11: Photodynamic diagnosis in flexible cystoscopy-a randomized study with focus on recurrence","volume":"137","author":"Drejer","year":"2020","journal-title":"Urology"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0086|cit86","unstructured":"Prospective, open, tricenter phase-III diagnostic trial to evaluate cystoscopic diagnosis of non-muscle invasive bladder cancer through narrow band imaging (NBI) in comparison to white light and photodynamic diagnosis (PDD) www.drks.de\/drks_web\/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00000142"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0087|cit87","unstructured":"A randomized, comparative, controlled phase III, multicenter study of hexvix fluorescence cystoscopy and white light cystoscopy in the detection of papillary bladder cancer and the early recurrence rate in patients with bladder cancer www.who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2004-002259-15-AT"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0088|cit88","unstructured":"Treatment of non-invasive bladder cancer with high risk of recurrence-blue light cystoscopy with chemotherapy www.who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2012-000559-15-FI"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0089|cit89","unstructured":"Comparison of white light transurethral\u00a0resection (TUR) vs photodynamic diagnosis (PDD)-guided TUR as assessed by second look TUR for the treatment of high risk non muscle invasive bladder cancer (NMIBC) www.who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2013-003898-98-IT"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0090|cit90","unstructured":"Photodynamic diagnosis (PDD) in flexible cystoscopy-a randomized study with focus on significant recurrence www.who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2015-000436-15-DK"},{"issue":"10","key":"10.1002\/14651858.CD013776.pub2-BIB0091|cit91","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1007\/s00120-003-0355-y","article-title":"Reducing the risk of superficial bladder cancer recurrence with 5-aminolevulinic acid-induced fluorescence diagnosis. Results of a 5-year study","volume":"42","author":"Filbeck","year":"2003","journal-title":"Urologe A"},{"issue":"1","key":"10.1002\/14651858.CD013776.pub2-BIB0092|cit92","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.juro.2007.03.028","article-title":"PC B302\/01 Study Group. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study","volume":"178","author":"Fradet","year":"2007","journal-title":"Journal of Urology"},{"issue":"12","key":"10.1002\/14651858.CD013776.pub2-BIB0093|cit93","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/s00345-017-2077-6","article-title":"'Real-life experience': recurrence rate at 3\u00a0years with Hexvix\u00ae\u00a0photodynamic diagnosis-assisted TURBT compared with good quality white light TURBT in new NMIBC-a prospective controlled study","volume":"35","author":"Gallagher","year":"2017","journal-title":"World Journal of Urology"},{"issue":"6","key":"10.1002\/14651858.CD013776.pub2-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1089\/end.2008.0574","article-title":"Hexaminolevulinate fluorescence cystoscopy and transurethral resection of the bladder in noninvasive bladder tumors","volume":"23","author":"Geavlete","year":"2009","journal-title":"Journal of Endourology"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0095|cit95","unstructured":"A randomised study of 'bluelight' hexyl aminolevulinic acid (HAL) photodynamic assisted resection of bladder tumours versus conventional 'whitelight' transurethral resection of newly diagnosed bladder tumours comparing rates of tumour recurrence over one www.isrctn.com\/ISRCTN14275387"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0096|cit96","unstructured":"Photodynamic diagnosis of bladder cancer using fluorescence cystoscopy with 5-aminolevulinic acid (5-ALA) upload.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000001625"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0097|cit97","unstructured":"Placebo controlled, randomized trial, comparing the efficacy of white light cystoscopy with the fluorescence cystoscopy with the use of hexaminolevulinate, regarding the diagnosis and treatment of bladder cancer upload.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000002279"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0098|cit98","unstructured":"The impact of PDD for urological cancer www.who.int\/trialsearch\/Trial2.aspx?TrialID=JPRN-UMIN000009093"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0099|cit99","unstructured":"Photodynamic diagnosis of non muscle invasive bladder cancer using fluorescence cystoscopy with oral administration of 5-aminolevulinic acid (5-ALA) upload.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000012641"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0100|cit100","unstructured":"Effectiveness of ALA-induced photodynamic diagnosis of bladder cancer on TURBT upload.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000035923"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0101|cit101","unstructured":"Bladder cancer prospective cohort study on high-risk non-muscle invasive cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor\u00a0(BRIGHT study) upload.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000040650"},{"issue":"1","key":"10.1002\/14651858.CD013776.pub2-BIB0102|cit102","first-page":"55","article-title":"The value of photodynamic diagnosis (PDD) in identifying carcinoma in situ (Cis) of urinary bladder","volume":"49","year":"2008","journal-title":"Clinical and Experimental Medical Letters"},{"issue":"3","key":"10.1002\/14651858.CD013776.pub2-BIB0103|cit103","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3109\/21681805.2015.1019562","article-title":"Reducing recurrence in non-muscle-invasive bladder cancer using photodynamic diagnosis and immediate post-transurethral resection of the bladder chemoprophylaxis","volume":"49","author":"Lykke","year":"2015","journal-title":"Scandinavian Journal of\u00a0Urology"},{"issue":"2","key":"10.1002\/14651858.CD013776.pub2-BIB0104|cit104","first-page":"47","article-title":"The comparison of recurrence rate of non-muscle invasive bladder cancer treated with fluorescence-guided and conventional transurethral resection","volume":"12","year":"2009","journal-title":"Onkologia Polska"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0105|cit105","unstructured":"Cystoscopy and hexyl 5-aminolevulinate in detecting carcinoma in situ in patients with bladder cancer www.clinicaltrials.gov"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0106|cit106","unstructured":"Cystoscopy and hexyl 5-aminolevulinate in detecting carcinoma in situ in patients with bladder cancer clinicaltrials.gov\/ct2\/show\/NCT00052637"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0107|cit107","unstructured":"A randomized, comparative study of hexvix\u00a0fluorescence cystoscopy and standard cystoscopy in patients with non-invasive bladder cancer clinicaltrials.gov\/show\/NCT00412971"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0108|cit108","unstructured":"Recurrence of bladder cancer after transurethral resection with hexvix clinicaltrials.gov\/ct2\/show\/NCT00785694"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0109|cit109","unstructured":"Longer-term recurrence rates in patients with bladder cancer after hexvix (Cysview) fluorescence cystoscopy\/TURB clinicaltrials.gov\/show\/NCT01166230"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0110|cit110","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4137\/cmo.s1012","article-title":"Photodynamic diagnosis for superficial bladder cancer: do all risk-groups profit equally from oncological and economic long-term results?","volume":"3","author":"Otto","year":"2009","journal-title":"Clinical Medicine Insights: Oncology"},{"issue":"4","key":"10.1002\/14651858.CD013776.pub2-BIB0111|cit111","doi-asserted-by":"publisher","first-page":"351","DOI":"10.5173\/ceju.2019.0003","article-title":"Efficacy of fluorescent cystoscopy-assisted transurethral resection in patients with non-muscle invasive bladder cancer and quality of surgery: post-hoc analysis of \u0430 prospective randomized study","volume":"72","author":"Rolevich","year":"2019","journal-title":"Central European Journal of\u00a0Urology"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0112|cit112","unstructured":"Treatment of non-invasive bladder cancer with high risk of recurrence-blue light cystoscopy with chemotherapy www.clinicaltrialsregister.eu\/ctr-search\/trial\/2006-000296-15\/HU"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0113|cit113","unstructured":"Fluorescence cystoscopy and optimized MMC in recurrent bladder cancer (FinnBladder 9) clinicaltrials.gov\/ct2\/show\/NCT01675219"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0114|cit114","unstructured":"Photodynamic versus white light-guided treatment of non-muscle invasive bladder cancer http:\/\/www.isrctn.com\/ISRCTN84013636"},{"issue":"9","key":"10.1002\/14651858.CD013776.pub2-BIB0115|cit115","doi-asserted-by":"publisher","first-page":"e022268","DOI":"10.1136\/bmjopen-2018-022268","article-title":"Photodynamic versus white light-guided treatment of non-muscle invasive bladder cancer: a study protocol for a randomised trial of clinical and cost-effectiveness","volume":"9","author":"Tandogdu","year":"2019","journal-title":"BMJ Open"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0116|cit116","doi-asserted-by":"crossref","unstructured":"Chang SS Boorjian SA Chou R Clark PE Daneshmand S Konety BR Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO joint guideline (2016) Available from www.auanet.org\/guidelines\/bladder-cancer-non-muscle-invasive-guideline","DOI":"10.1016\/j.juro.2016.06.049"},{"issue":"7","key":"10.1002\/14651858.CD013776.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1089\/end.2021.0241","article-title":"Editorial comment on: 'Primary complete transurethral resection of bladder tumor using photodynamic diagnosis for high-risk nonmuscle invasive bladder cancer: is a restaging photodynamic transurethral resection really necessary?' by Tadrist et al","volume":"35","author":"Bogdan","year":"2021","journal-title":"Journal of Endourology"},{"issue":"6","key":"10.1002\/14651858.CD013776.pub2-BIB0118|cit118","doi-asserted-by":"publisher","first-page":"394-424","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"2","key":"10.1002\/14651858.CD013776.pub2-BIB0119|cit119","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer","volume":"63","author":"Burger","year":"2013","journal-title":"European Urology"},{"issue":"3 Pt 1","key":"10.1002\/14651858.CD013776.pub2-BIB0120|cit120","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.juro.2016.10.061","article-title":"Comparative effectiveness of fluorescent versus white light cystoscopy for initial diagnosis or surveillance of bladder cancer on clinical outcomes: systematic review and meta-analysis","volume":"197","year":"2017","journal-title":"Journal of Urology"},{"issue":"2","key":"10.1002\/14651858.CD013776.pub2-BIB0121|cit121","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The Clavien-Dindo classification of surgical complications: five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Annals of Surgery"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0122|cit122","unstructured":"Veritas Health Innovation Covidence 2021"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0123|cit123","unstructured":"Deeks JJ Higgins JPT Altman DG Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s).\u00a0Cochrane Handbook for Systematic Reviews of Interventions\u00a0version 6.0 (updated July 2019). Cochrane, 2019 Available from\u00a0training.cochrane.org\/handbook\/archive\/v6"},{"issue":"6","key":"10.1002\/14651858.CD013776.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.purol.2019.04.001","article-title":"[Is a routine second transurethral resection of the bladder still necessary after hexaminolevulinate photodynamic diagnosis-assisted TURBT?]","volume":"29","author":"Doisy","year":"2019","journal-title":"Prog Urol"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0125|cit125","unstructured":"Babjuk M Burger M Comp\u00e9rat E Gontero P Liedberg F Masson-Lecomte A EAU Guideline on non-muscle-invasive bladder cancer uroweb.org\/guideline\/non-muscle-invasive-bladder-cancer\/"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0126|cit126","unstructured":"EndNote Thomson Reuters 2019"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0127|cit127","unstructured":"Cysview (hexaminolevulinate hydrochloride), for intravesical\u00a0solution for bladder instillation only www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/022555s000lbl.pdf"},{"issue":"10","key":"10.1002\/14651858.CD013776.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00345-015-1485-8","article-title":"Fluorescence-guided bladder tumour resection: impact on survival after radical cystectomy","volume":"33","author":"Gakis","year":"2015","journal-title":"World Journal of Urology"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0129|cit129","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2021"},{"issue":"7651","key":"10.1002\/14651858.CD013776.pub2-BIB0130|cit130","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"GRADE: what is \"quality of evidence\" and why is it important to clinicians?","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD013776.pub2-BIB0131|cit131","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD013776.pub2-BIB0132|cit132","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009294.pub3","article-title":"Intravesical gemcitabine for non-muscle invasive bladder cancer","author":"Han","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD013776.pub2-BIB0133|cit133","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"7414","key":"10.1002\/14651858.CD013776.pub2-BIB0134|cit134","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for\u00a0assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0136|cit136","doi-asserted-by":"crossref","unstructured":"Higgins JPT Thomas J Chandler J Cumpston M Li T Page MJ Welch VA Cochrane Handbook for Systematic Reviews of Interventions\u00a0version 6.0 (updated July 2019). Cochrane, 2019 Available from training.cochrane.org\/handbook\/archive\/v6","DOI":"10.1002\/9781119536604"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0137|cit137","doi-asserted-by":"crossref","unstructured":"Higgins JPT Eldridge S Li T Chapter 23: Including variants on randomized trials. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s).\u00a0Cochrane Handbook for Systematic Reviews of Interventions\u00a0version 6.0 (updated July 2019). Cochrane, 2019 Available from training.cochrane.org\/handbook\/archive\/v6","DOI":"10.1002\/9781119536604"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0138|cit138","unstructured":"Higgins JPT \u00a0Savovi\u0107 J Page MJ Elbers RG Sterne JAC Chapter 8: Assessing risk of bias in a randomized study. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s).\u00a0Cochrane Handbook for Systematic Reviews of Interventions\u00a0version 6.0 (updated July 2019). Cochrane, 2019 Available from training.cochrane.org\/handbook\/archive\/v6"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0139|cit139","unstructured":"Higgins JPT Thomas J Chandler J Cumpston M Li T Page MJ Welch VA Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jclinepi.2017.05.006","article-title":"The GRADE Working Group clarifies the construct of certainty of evidence","volume":"87","author":"Hultcrantz","year":"2017","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD013776.pub2-BIB0141|cit141","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: prostate and bladder tumours","volume":"70","author":"Humphrey","year":"2016","journal-title":"European Urology"},{"issue":"5","key":"10.1002\/14651858.CD013776.pub2-BIB0142|cit142","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013160.pub2","article-title":"Single-dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma","author":"Hwang","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD013776.pub2-BIB0143|cit143","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/iju.13291","article-title":"5-aminolevulinic acid-mediated photodynamic therapy for bladder\u00a0cancer","volume":"24","author":"Inoue","year":"2017","journal-title":"International Journal of Urology"},{"issue":"6","key":"10.1002\/14651858.CD013776.pub2-BIB0144|cit144","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.eururo.2007.11.048","article-title":"Photodynamic diagnosis in urology: state-of-the-art","volume":"53","author":"Jocham","year":"2008","journal-title":"European Urology"},{"issue":"1","key":"10.1002\/14651858.CD013776.pub2-BIB0145|cit145","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009294.pub2","article-title":"Intravesical gemcitabine for non-muscle invasive bladder cancer","author":"Jones","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD013776.pub2-BIB0146|cit146","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011864.pub2","article-title":"Intravesical electromotive drug administration for non-muscle invasive bladder cancer","author":"Jung","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD013776.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"173","DOI":"10.5489\/cuaj.4568","article-title":"Contemporary cost-consequence analysis of blue light cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer","volume":"11","author":"Klaassen","year":"2017","journal-title":"Canadian Urological Association Journal"},{"issue":"5","key":"10.1002\/14651858.CD013776.pub2-BIB0148|cit148","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1562\/0031-8655(2002)076<0518:mcotcs>2.0.co;2","article-title":"Metabolic characterization of tumor cell-specific protoporphyrin IX accumulation after exposure to 5-aminolevulinic acid in human colonic cells","volume":"76","author":"Krieg","year":"2002","journal-title":"Photochemistry and Photobiology"},{"issue":"3","key":"10.1002\/14651858.CD013776.pub2-BIB0149|cit149","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014887","article-title":"Narrow band imaging versus white light cystoscopy alone for transurethral resection of non-muscle invasive bladder cancer","author":"Lai","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD013776.pub2-BIB0150|cit150","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.juro.2013.07.102","article-title":"Defining progression in nonmuscle invasive bladder cancer: it is time for a new, standard definition","volume":"191","author":"Lamm","year":"2014","journal-title":"Journal of Urology"},{"issue":"7","key":"10.1002\/14651858.CD013776.pub2-BIB0151|cit151","doi-asserted-by":"publisher","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLOS Medicine"},{"issue":"11","key":"10.1002\/14651858.CD013776.pub2-BIB0152|cit152","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013776","article-title":"Blue versus white light for transurethral resection of non-muscle invasive bladder cancer","author":"Maisch","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD013776.pub2-BIB0153|cit153","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1017\/S0266462310001364","article-title":"Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: systematic review and meta-analysis","volume":"27","author":"Mowatt","year":"2011","journal-title":"International Journal of Technology Assessment in Health Care"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0154|cit154","unstructured":"\u00a0Bangs R \u00a0Buyyounousi MK National Comprehensive Cancer Network Guidelines Version 5.2020 Bladder Cancer, 2020 Available from www.nccn.org\/professionals\/physician_gls\/PDF\/bladder.pdf"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0155|cit155","unstructured":"Bladder cancer: diagnosis and management, NICE guideline [NG2], 2015 Available from\u00a0www.nice.org.uk\/guidance\/ng2"},{"issue":"1","key":"10.1002\/14651858.CD013776.pub2-BIB0156|cit156","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/bju.13020","article-title":"Effectiveness of hexaminolevulinate fluorescence cystoscopy for the diagnosis of non-muscle-invasive bladder cancer in daily clinical practice: a spanish multicentre observational study","volume":"116","author":"Palou","year":"2015","journal-title":"BJU International"},{"issue":"24","key":"10.1002\/14651858.CD013776.pub2-BIB0157|cit157","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1002\/(sici)1097-0258(19981230)","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"issue":"6","key":"10.1002\/14651858.CD013776.pub2-BIB0158|cit158","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/j.1464-410X.2009.08839.x","article-title":"Hexylaminolaevulinate fluorescence cystoscopy in patients previously treated with intravesical bacille Calmette-Gu\u00e9rin","volume":"105","author":"Ray","year":"2010","journal-title":"BJU International"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0159|cit159","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"4","key":"10.1002\/14651858.CD013776.pub2-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.eururo.2013.07.007","article-title":"Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature","volume":"64","author":"Rink","year":"2013","journal-title":"European Urology"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jclinepi.2019.10.014","article-title":"GRADE guidelines 26: Informative statements to communicate the findings of systematic reviews of interventions","volume":"119","author":"Santesso","year":"2020","journal-title":"Journal of Clinical Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD013776.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/bju.15383","article-title":"Impact of enhanced optical techniques at time of transurethral resection of bladder tumour, with or without single immediate intravesical chemotherapy, on recurrence rate of non-muscle-invasive bladder cancer: a systematic review and network meta-analysis of randomized trials","volume":"128","author":"Sari Motlagh","year":"2021","journal-title":"BJU International"},{"issue":"1","key":"10.1002\/14651858.CD013776.pub2-BIB0163|cit163","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011935.pub2","article-title":"Intravesical bacillus calmette-gu\u00e9rin versus mitomycin C for Ta and T1 bladder cancer","author":"Schmidt","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0164|cit164","doi-asserted-by":"publisher","first-page":"283670","DOI":"10.5402\/2012\/283670","article-title":"Analysis of the distribution and temporal trends of grade and stage in urothelial bladder cancer in northern new england from 1994 to 2004","volume":"2012","author":"Schned","year":"2012","journal-title":"ISRN Pathology"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0165|cit165","doi-asserted-by":"crossref","unstructured":"Sch\u00fcnemann HJ Higgins JPT Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s).\u00a0Cochrane Handbook for Systematic Reviews of Interventions\u00a0version 6.0 (updated July 2019). Cochrane, 2019 Available from training.cochrane.org\/handbook\/archive\/v6","DOI":"10.1002\/9781119536604.ch14"},{"issue":"3","key":"10.1002\/14651858.CD013776.pub2-BIB0166|cit166","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012112.pub2","article-title":"Intravesical Bacillus Calmette-Gu\u00e9rin with interferon-alpha versus intravesical Bacillus Calmette-Gu\u00e9rin for treating non-muscle-invasive bladder cancer","author":"Shepherd","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD013776.pub2-BIB0167|cit167","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"European Urology"},{"issue":"7","key":"10.1002\/14651858.CD013776.pub2-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1089\/end.2020.1107","article-title":"Primary complete transurethral resection of bladder tumor using photodynamic diagnosis for high-risk nonmuscle invasive bladder cancer: is a restaging photodynamic transurethral resection really necessary?","volume":"35","author":"Tadrist","year":"2021","journal-title":"Journal of Endourology"},{"issue":"16","key":"10.1002\/14651858.CD013776.pub2-BIB0169|cit169","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1745-6215-8-1","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"10.1002\/14651858.CD013776.pub2-BIB0170|cit170","volume-title":"www.cadth.ca\/sites\/default\/files\/pdf\/htis\/2017\/RC0848_Blue%20Light%20Cystoscopy_Final.pdf","author":"Tran","year":"2017"},{"issue":"1","key":"10.1002\/14651858.CD013776.pub2-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.urology.2014.03.006","article-title":"Safety of hexaminolevulinate for blue light cystoscopy in bladder cancer. A combined analysis of the trials used for registration and postmarketing data","volume":"84","author":"Witjes","year":"2014","journal-title":"Urology"},{"issue":"5","key":"10.1002\/14651858.CD013776.pub2-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.eururo.2014.06.037","article-title":"Clinical and cost effectiveness of hexaminolevulinate-guided blue-light cystoscopy: evidence review and updated expert recommendations","volume":"66","author":"Witjes","year":"2014","journal-title":"European Urology"},{"issue":"5","key":"10.1002\/14651858.CD013776.pub2-BIB0173|cit173","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.eursup.2007.12.007","article-title":"Cystoscopy in bladder cancer: the case pro","volume":"7","author":"Witjes","year":"2018","journal-title":"European Urology Supplements"},{"issue":"7644","key":"10.1002\/14651858.CD013776.pub2-BIB0174|cit174","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect\u00a0estimates in controlled trials with different interventions\u00a0and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ"},{"issue":"11","key":"10.1002\/14651858.CD013776.pub2-BIB0175|cit175","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s00120-007-1563-7","article-title":"Fluorescence cystoscopy at bladder cancer: present trials","volume":"46","author":"\u00a0Karl","year":"2007","journal-title":"Urologe A"}],"updated-by":[{"DOI":"10.1002\/14651858.cd013776.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T17:53:04Z","timestamp":1673373184000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013776.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Urology Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":175,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013776.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,1]]}}}